American Portfolios Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $208K | Buy |
5,168
+2,515
| +95% | +$101K | 0.01% | 1005 |
|
|
2022
Q2 | $111K | Sell |
2,653
-442
| -14% | -$18.6K | ﹤0.01% | 1340 |
|
|
2022
Q1 | $140K | Sell |
3,095
-615
| -17% | -$27.8K | ﹤0.01% | 1343 |
|
|
2021
Q4 | $171K | Buy |
3,710
+3
| +0.1% | +$138 | 0.01% | 1236 |
|
|
2021
Q3 | $176K | Buy |
3,707
+77
| +2% | +$3.65K | 0.01% | 1172 |
|
|
2021
Q2 | $188K | Buy |
3,630
+1
| +0% | +$52 | 0.01% | 1124 |
|
|
2021
Q1 | $183K | Buy |
3,629
+559
| +18% | +$28.1K | 0.01% | 1061 |
|
|
2020
Q4 | $160K | Sell |
3,070
-50
| -2% | -$2.6K | 0.01% | 974 |
|
|
2020
Q3 | $136K | Buy |
3,120
+1
| +0% | +$43 | 0.01% | 952 |
|
|
2020
Q2 | $134K | Buy |
3,119
+151
| +5% | +$6.49K | 0.01% | 888 |
|
|
2020
Q1 | $107K | Sell |
2,968
-635
| -18% | -$22.9K | 0.01% | 872 |
|
|
2019
Q4 | $165K | Sell |
3,603
-324
| -8% | -$14.8K | 0.01% | 817 |
|
|
2019
Q3 | $140K | Sell |
3,927
-1,709
| -30% | -$60.8K | 0.01% | 840 |
|
|
2019
Q2 | $224K | Sell |
5,636
-693
| -11% | -$27.6K | 0.02% | 671 |
|
|
2019
Q1 | $263K | Buy |
6,329
+742
| +13% | +$30.9K | 0.02% | 552 |
|
|
2018
Q4 | $205K | Sell |
5,587
-99
| -2% | -$3.63K | 0.03% | 506 |
|
|
2018
Q3 | $276K | Buy |
5,686
+723
| +15% | +$35.1K | 0.03% | 473 |
|
|
2018
Q2 | $213K | Sell |
4,963
-4,289
| -46% | -$184K | 0.03% | 518 |
|
|
2018
Q1 | $387K | Buy |
9,252
+1,388
| +18% | +$58.1K | 0.06% | 323 |
|
|
2017
Q4 | $342K | Buy |
+7,864
| New | +$342K | 0.05% | 346 |
|